RVRevvity RVTY · NYSE
$150.85 -1.17% (-$1.79)
- Market cap
- $17.0B
- Enterprise value
- $19.3B
- P/E
- 71.7x
- Forward P/E
- 26.2x
- PEG
- -
- P/S
- 5.8x
- P/FCF
- 30.4x
- EV/EBITDA
- 25.2x
- ROIC
- 2.9%
- Bruto marža
- 52.1%
- Neto marža
- 8.2%
- Dividend yield
- 0.18%
- Payout ratio
- 13.2%
- Neto dolg/EBITDA
- 3.0x
- Beta
- 1.06
- Free float
- 91.9%
O podjetju
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. With a global network and localized agility, the company serves a diverse range of organizations from pharmaceutical and biotech to clinical labs, academia, and governments. It is headquartered in Waltham, MA.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Prahlad R. Singh
Employees
11,000
Headquarters
Waltham
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke